Non-immunodominant CD8+ T-cell responses can be harnessed to mount antitumor immunity in the tolerant HER-2/neu transgenic mice

被引：0
|
作者：
Uram, Jennifer [1 ]
Black, Chelsea [1 ]
Flynn, Emilee [1 ]
Huang, Lanqing [1 ]
Armstrong, Todd [1 ]
Jaffee, Elizabeth [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4165
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CD4+ T cell-released exosomes inhibit CD8+ cytotoxic T-lymphocyte responses and antitumor immunity
    Zhang, Haifeng
    Xie, Yufeng
    Li, Wei
    Chibbar, Rajni
    Xiong, Sidong
    Xiang, Jim
    CELLULAR & MOLECULAR IMMUNOLOGY, 2011, 8 (01) : 23 - 30
  • [42] A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
    Seavey, Matthew M.
    Pan, Zhen-Kun
    Maciag, Paulo C.
    Wallecha, Anu
    Rivera, Sandra
    Paterson, Yvonne
    Shahabi, Vafa
    CLINICAL CANCER RESEARCH, 2009, 15 (03) : 924 - 932
  • [43] Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent
    Johnson, C. Bryce
    Riesenberg, Brian P.
    May, Bennett R.
    Gilreath, Stuart C.
    Li, Guangfu
    Staveley-O'Carroll, Kevin F.
    Garrett-Mayer, Elizabeth
    Mehrotra, Shikhar
    Cole, David J.
    Rubinstein, Mark P.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) : 1364 - 1374
  • [44] Using HLA-transgenic mice to identify immunodominant human CD8+ T cell epitopes -: Does (genome) size matter?
    Terajima, M
    Ennis, FA
    IMMUNOLOGY LETTERS, 2006, 105 (01) : 97 - 98
  • [45] Synthetic, Supramolecular, and Self-Adjuvanting CD8+ T-Cell Epitope Vaccine Increases the Therapeutic Antitumor Immunity
    Yang, Pengxiang
    Song, Huijuan
    Feng, Zujian
    Wang, Changrong
    Huang, Pingsheng
    Zhang, Chuangnian
    Kong, Deling
    Wang, Weiwei
    ADVANCED THERAPEUTICS, 2019, 2 (07)
  • [46] CAN SOLUBLE-ANTIGENS INDUCE CD8+ CYTOTOXIC T-CELL RESPONSES - A PARADOX REVISITED
    RAYCHAUDHURI, S
    MORROW, WJW
    IMMUNOLOGY TODAY, 1993, 14 (07): : 344 - 348
  • [47] Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity
    Slebioda, Tomasz J.
    Rowley, Tania F.
    Ferdinand, John R.
    Willoughby, Jane E.
    Buchan, Sarah L.
    Taraban, Vadim Y.
    Al-Shamkhani, Aymen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (09) : 2606 - 2611
  • [48] Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8
    Lustgarten, J
    Theobald, M
    Labadie, C
    LaFace, D
    Peterson, P
    Disis, ML
    Cheever, MA
    Sherman, LA
    HUMAN IMMUNOLOGY, 1997, 52 (02) : 109 - 118
  • [49] Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors
    Nair, Raji E.
    Kilinc, Mehmet O.
    Jones, Stacy A.
    Egilmez, Nejat K.
    JOURNAL OF IMMUNOLOGY, 2006, 176 (12): : 7325 - 7334
  • [50] CD8+ T-cell based immunotherapy of pancreatic insulinomas in SV40 T antigen transgenic mice.
    Otahal, Pavel
    Schell, Todd
    Bartunkova, Jirina
    Tevethia, Satvir
    CLINICAL IMMUNOLOGY, 2006, 119 : S90 - S90
12345